On Friday (2/11/22), Barron’s featured our research for the first time in 2022 and 44th time since 2014. This time, Barron’s featured research from our report, Affirm’s Results Affirm Our Thesis: Sell This Stock, which uses our reverse DCF analysis to quantify how the high the future cash flow expectations baked into the stock’s valuation are.
See the Barron’s article here.
In addition, you can see all our media coverage here.